Translational Neural Devices (U44 Clinical Trial Optional)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Next predicted deadline: Oct 18, 2023 (Full proposal)

Later predicted deadlines: Feb 20, 2024 (Full proposal), Dec 20, 2024 (Letter of inquiry)

Grant amount: Up to US $1,000,000

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, Virgin Islands Show all

Overview:

NOTE: All applications are due by 5:00 PM local time of applicant organization.

The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from Small Business Concerns (SBCs) to pursue translational activities and small clinical studies to advance the development of therapeutic and diagnostic devices for disorders that affect the nervous or neuromuscular systems. The translational device activities, including translational bench and animal studies, are expected to lead to submission of an Investigational Device Exemption (IDE) to the U.S. Food and Drug Administration (FDA) or Institutional Review Board (IRB) application for a Non-Significant Risk (NSR) study. This cooperative agreement will also support the subsequent small clinical study to collect safety and effectiveness data required to support a marketing application or to inform final device design.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.